Adagio Medical Inc. company information, Employees & Contact Information

Adagio Medical Announces Pricing of up to $50 Million Private Placement of Securities Stock Titan

Adagio Medical Closes Financing of $19 Million Upfront Positions Company to Advance Purpose Built Technology for Treatment of Ventricular Tachycardia MarketScreener

Adagio Medical prices $50M private placement MassDevice

97.4% Acute Clinical Success: Adagio Medical ULTC Eliminates VT in 96.7% of 207 Patients Stock Titan

Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference | User | ricentral.com FinancialContent

First VT-Specific Ablation Technology: Adagio Medical Completes Breakthrough Device Trial With 208 Patients Stock Titan

Adagio Medical to restructure, reduce workforce MassDevice

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies PR Newswire

Reed Smith advises Adagio Medical on closing of business combination with ARYA Sciences Acquisition Corp IV Reed Smith LLP

Adagio Medical cuts workforce and pauses cryo catheter launch in EU Medical Device Network

First Major Ultralow Temperature Cryoablation VT Trial Results: Adagio Medical's FULCRUM-VT Study Data Coming Stock Titan

Adagio Medical wins FDA breakthrough nod for cryoablation tech MassDevice

Arrhythmia ablation tech maker Adagio Medical picks up the tempo with $128M SPAC deal Fierce Biotech

Adagio Medical Announces Initiation and First Procedure in FULCRUM-VT Trial, Starting The Process For Bringing Ultra-Low Temperature Cryoablation for Ventricular Arrhythmias to US Market PR Newswire

Adagio Medical secures $19m to support ULTC system Medical Device Network

Adagio Medical Raises $42.5 Million In Series E Financing PR Newswire

Adagio Medical Announces Initiation and First Patient Enrollment in PARALELL Trial To Investigate Safety and Performance of CryoPulse™ Catheter System for Pulsed Field Ablation and Pulsed Field Cryoablation of Persistent Atrial Fibrillation PR Newswire

Adagio Medical goes public in SPAC merger MassDevice

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers PR Newswire

Adagio Medical Announces First Patient Enrollment in its iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial Fibrillation PR Newswire

Adagio Medical Holdings ends agreement with Fjord Ventures Investing.com

Pulsed Field Cryoablation Eliminated AF in 85% After Single Ablation Procedure Diagnostic and Interventional Cardiology

Adagio Medical wins FDA IDE for cryoablation study, completes first commercial cases in Europe MassDevice

Adagio Medical picks medtech veteran Todd Usen as new CEO MassDevice

Ablation tech developer Adagio Medical to go public in SPAC deal MassDevice

First patients treated using Adagio Medical’s pulsed field cryoablation system Cardiac Rhythm News